AADAC Antikörper
-
- Target Alle AADAC Antikörper anzeigen
- AADAC (Arylacetamide Deacetylase (Esterase) (AADAC))
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser AADAC Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
- Produktmerkmale
- Polyclonal Antibody
- Aufreinigung
- Affinity purification
- Immunogen
- Recombinant protein of human AADAC
- Isotyp
- IgG
- Top Product
- Discover our top product AADAC Primärantikörper
-
anti-Arylacetamide Deacetylase (Esterase) (AADAC) (AA 273-300), (C-Term) antibody
AADAC Reaktivität: Human WB, FACS, IHC (p) Wirt: Kaninchen Polyclonal RB19675 unconjugated
anti-Arylacetamide Deacetylase (Esterase) (AADAC) (AA 201-300) antibodyAADAC Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal 2E8 unconjugated
anti-Arylacetamide Deacetylase (Esterase) (AADAC) (AA 24-399) antibodyAADAC Reaktivität: Human ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Arylacetamide Deacetylase (Esterase) (AADAC) (AA 170-399) antibodyAADAC Reaktivität: Human WB, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Arylacetamide Deacetylase (Esterase) (AADAC) (AA 273-300) antibodyAADAC Reaktivität: Human WB, ELISA, IHC, FACS Wirt: Kaninchen Polyclonal unconjugated
anti-Arylacetamide Deacetylase (Esterase) (AADAC) antibodyAADAC Reaktivität: Human WB, IHC, FACS Wirt: Kaninchen Polyclonal unconjugated
anti-Arylacetamide Deacetylase (Esterase) (AADAC) (AA 228-273) antibodyAADAC Reaktivität: Maus, Ratte WB, ELISA, IF (cc), IF (p), IHC (p), IHC (fro), ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Arylacetamide Deacetylase (Esterase) (AADAC) (AA 201-300) antibodyAADAC Reaktivität: Human WB, ELISA Wirt: Maus Polyclonal unconjugated
anti-Arylacetamide Deacetylase (Esterase) (AADAC) antibodyAADAC Reaktivität: Human, Maus, Ratte IF Wirt: Kaninchen Polyclonal unconjugated
anti-Arylacetamide Deacetylase (Esterase) (AADAC) (AA 170-399) antibodyAADAC Reaktivität: Human WB, IHC Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- WB 1:500-1:2000, IHC 1:50-1:100
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.2 mg/mL
- Buffer
- PBS with 0.05 % sodium azide and 50 % glycerol, PH7.4
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Target
- AADAC (Arylacetamide Deacetylase (Esterase) (AADAC))
- Andere Bezeichnung
- AADAC (AADAC Produkte)
- Synonyme
- MGC89272 antikoerper, AADAC antikoerper, CES5A1 antikoerper, DAC antikoerper, Aada antikoerper, 5033417E09Rik antikoerper, AI265437 antikoerper, arylacetamide deacetylase antikoerper, arylacetamide deacetylase S homeolog antikoerper, Arylacetamide deacetylase antikoerper, arylacetamide deacetylase (esterase) antikoerper, LOC100056411 antikoerper, aadac antikoerper, AADAC antikoerper, aadac.S antikoerper, LOC100451808 antikoerper, ACD3 antikoerper, PTRG_10278 antikoerper, aaad antikoerper, Aadac antikoerper
- Hintergrund
- Microsomal arylacetamide deacetylase competes against the activity of cytosolic arylamine N-acetyltransferase, which catalyzes one of the initial biotransformation pathways for arylamine and heterocyclic amine carcinogens. Arylacetamide deacetylation is an important enzyme activity in the metabolic activation of arylamine substrates to ultimate carcinogens. Displays major serine hydrolase activity in liver microsomes. Hydrolyzes also flutamide, which is an antiandrogen drug used for the treatment of prostate cancer that occasionally causes severe hepatotoxicity. Displays cellular triglyceride lipase activity in liver. Increases intracellular fatty acids derived from hydrolysis of newly formed triglyceride stores.
- Molekulargewicht
- 46 kDa
- UniProt
- P22760
-
